Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Prespecified Secondary End Points in ORION 1
暂无分享,去创建一个
Lawrence A Leiter | J. Kastelein | U. Landmesser | R. Wright | D. Kallend | P. Wijngaard | K. Ray | R. Stoekenbroek
暂无分享,去创建一个
Lawrence A Leiter | J. Kastelein | U. Landmesser | R. Wright | D. Kallend | P. Wijngaard | K. Ray | R. Stoekenbroek